Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate vs Placebo for Chronic Migraine Prophylaxis
NCT00210912Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Sep 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of topiramate in chronic migraine, sponsored by Johnson & Johnson. Started Sep 2003; status: completed.
02
Drugs
topiramate
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT00210912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210912.